1CM
BEAT

1492 Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

1492 Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,643
Closed -$526K – 107
2020
Q2 		$526K Sell
11,643
-31
-0.3% -$1.39K 0.45% 57
2020
Q1 		$450K Sell
11,674
-53,514
-82% -$2.46M 0.54% 54
2019
Q4 		$3.02M Buy
65,188
+4,622
+8% +$200K 2.67% 9
2019
Q3 		$2.47M Sell
60,566
-326
-0.5% -$14.1K 2.41% 11
2019
Q2 		$2.93M Sell
60,892
-2,738
-4% -$144K 2.74% 9
2019
Q1 		$3.98M Sell
63,630
-17,521
-22% -$1.2M 3.37% 7
2018
Q4 		$4.85M Sell
81,151
-36,697
-31% -$2.2M 4.34% 2
2018
Q3 		$7.59M Sell
117,848
-277
-0.2% -$15.5K 4.94% 3
2018
Q2 		$5.32M Sell
118,125
-819
-0.7% -$32.7K 3.8% 3
2018
Q1 		$3.69M Sell
118,944
-4,706
-4% -$155K 2.84% 7
2017
Q4 		$3.7M Sell
123,650
-754
-0.6% -$21.8K 2.88% 6
2017
Q3 		$4.11M Sell
124,404
-253
-0.2% -$8.76K 3.63% 4
2017
Q2 		$4.17M Sell
124,657
-36,238
-23% -$1.08M 3.68% 3
2017
Q1 		$4.66M Sell
160,895
-39,236
-20% -$972K 3.62% 4
2016
Q4 		$4.47M Sell
200,131
-72,715
-27% -$1.42M 3.45% 3
2016
Q3 		$5.07M Sell
272,846
-12,931
-5% -$244K 4.14% 1
2016
Q2 		$4.66M Sell
285,777
-10,700
-4% -$157K 4.18% 1
2016
Q1 		$3.46M Sell
296,477
-25,284
-8% -$283K 2.93% 7
2015
Q4 		$3.76M Buy
321,761
+32,932
+11% +$417K 2.73% 10
2015
Q3 		$3.54M Buy
288,829
+171,915
+147% +$2.19M 2.52% 10
2015
Q2 		$1.1M Sell
116,914
-87
-0.1% -$805 0.7% 37
2015
Q1 		$1.03M Sell
117,001
-9,619
-8% -$97.2K 0.6% 39
2014
Q4 		$1.27M Sell
126,620
-1,359
-1% -$11.7K 0.8% 31
2014
Q3 		$859K Sell
127,979
-8,749
-6% -$61.3K 0.48% 53
2014
Q2 		$980K Buy
136,728
+44,665
+49% +$355K 0.5% 55
2014
Q1 		$929K Buy
+92,063
New +$847K 0.46% 60

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

1492 Capital Management's BEAT Position: Q3 2020 in Review

1492 Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 11,643 shares — an estimated $526K sold.

1492 Capital Management first reported a position in BEAT in Q1 2014 and held it in 26 quarters. The position peaked at $7.59M in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • 1492 Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • 1492 Capital Management sold 11,643 BioTelemetry, Inc. shares in Q3 2020, an estimated $526K.
  • 1492 Capital Management first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 26 quarters.
  • 1492 Capital Management's BioTelemetry, Inc. position peaked at $7.59M in Q3 2018.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on 1492 Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.